QDEL.NASDAQQuidelortho CORP

Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


The Carlyle Group continues to reduce its stake in QuidelOrtho Corp (QDEL) through a series of sales executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of shares of common stock.
  • The sales occurred on July 18 and July 19, 2024.
  • The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
  • On July 18, 2024, Carlyle sold 53,224 shares at a weighted average price of $33.4592, 32,989 shares at a weighted average price of $34.7526, and 15,657 shares at a weighted average price of $35.0852.
  • On July 19, 2024, Carlyle sold 1,500 shares at $32.93, 21,182 shares at a weighted average price of $33.5406, and 42,954 shares at a weighted average price of $34.4528.
  • Following these transactions, Carlyle's indirect beneficial ownership stands at 10,562,558 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions. The sales themselves could be viewed as slightly negative, but the existence of a 10b5-1 plan mitigates this.

Negatives

  • Carlyle Group, a major shareholder, is reducing its position in QuidelOrtho, which could be perceived negatively by the market.

Risks

  • Continued sales by Carlyle Group could put downward pressure on QuidelOrtho's stock price.
  • The market may interpret these sales as a lack of confidence in the company's future prospects, regardless of the reason for the sales.

Future Outlook

The document does not provide a future outlook for QuidelOrtho Corp.

Industry Context

Share sales by major holders are common and can be for various reasons, including portfolio rebalancing or profit-taking. The impact on QuidelOrtho will depend on market perception and the overall health of the diagnostics industry.

Stakeholder Impact

  • Shareholders may react to the news of Carlyle's share sales.
  • The sales could potentially affect the stock price in the short term.

Key Dates

DateDescription
05/12/2024Date of adoption of the Rule 10b5-1 trading plan.
07/18/2024Date of first reported transaction (share sales).
07/19/2024Date of second reported transaction (share sales).
07/22/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.